STOCK TITAN

Long Path discloses 7.3% stake in Mesa Labs (NASDAQ: MLAB)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Long Path funds and affiliated managers amend a Schedule 13G to report ownership of 405,583 shares of Mesa Laboratories, Inc. Common Stock, equal to 7.3% of the class. Percentage is based on 5,524,813 shares outstanding as of January 31, 2026. The shares are directly held by Long Path Smaller Companies Fund, LP; the Reporting Persons disclaim beneficial ownership except to the extent of their pecuniary interest. This filing is Amendment No. 1 to the previously filed Schedule 13G.

Positive

  • None.

Negative

  • None.

Insights

Long Path reports a meaningful passive stake (7.3%) in Mesa Laboratories.

The filing shows the Fund holds 405,583 shares, with voting and dispositive power reported as shared among listed entities and individuals. The 7.3% figure uses the issuer's disclosed outstanding share count as of January 31, 2026.

Because this is a Schedule 13G amendment, it indicates passive investment reporting rather than an activist intent; subsequent filings would show any change in intent or ownership size.

Reported shares held 405,583 shares Directly held by Long Path Smaller Companies Fund, LP
Percent of class 7.3% Calculated using 5,524,813 shares outstanding as of 01/31/2026
Form type Schedule 13G/A (Amendment No. 1) Amendment to prior 13G filed March 13, 2026
Shares outstanding (context) 5,524,813 shares Issuer's Form 10-Q for period ended 12/31/2025 (as of 01/31/2026)
Schedule 13G/A regulatory
"This Amendment No. 1 to the Schedule 13G is filed by"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial ownership financial
"Each Reporting Person disclaims beneficial ownership of such shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared dispositive power financial
"Shared Dispositive Power 405,583.00"





59064R109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Long Path Smaller Companies Fund, LP
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member of Long Path Fund GP, LLC, its general partner
Date:04/15/2026
Long Path Fund GP, LLC
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member
Date:04/15/2026
Long Path Partners, LP
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member of Long Path Holdings LLC, its general partner
Date:04/15/2026
Long Path Holdings LLC
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member
Date:04/15/2026
William Thomas Brennan
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/individually
Date:04/15/2026
Brian Paul Nelson
Signature:/s/ Brian Paul Nelson
Name/Title:Brian Paul Nelson/individually
Date:04/15/2026

FAQ

What stake does Long Path report in Mesa Laboratories (MLAB)?

Long Path reports ownership of 405,583 shares, representing 7.3% of common stock. This percentage uses a base of 5,524,813 shares outstanding as of January 31, 2026 per the issuer's 10-Q.

Who exactly filed the Schedule 13G/A for Mesa Laboratories (MLAB)?

The amendment is filed jointly by Long Path Smaller Companies Fund, LP; Long Path Fund GP, LLC; Long Path Partners, LP; Long Path Holdings LLC; William T. Brennan; and Brian P. Nelson, as Reporting Persons.

Are the reported shares directly held or beneficially owned by the managers?

The shares are directly held by Long Path Smaller Companies Fund, LP. The Reporting Persons disclaim beneficial ownership except to the extent of their pecuniary interest in the Fund.

What date is used to calculate the percentage ownership in the filing?

Percentage ownership is calculated using 5,524,813 shares outstanding as of January 31, 2026, as reported in the issuer's Form 10-Q for the period ended December 31, 2025.